Trademark: QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
Mark Identification
QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
Proof of use for QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
We do not have any records of a proof of use for QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG at this moment.
Possible trademark infringements of QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
Basic Information about QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
- Serial Number
- 90287844
- Filing Date
- 29 Oct 2020
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG on the blockchain with WikiTrademarks.io.
- First use of QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG?
1. Supernus Pharmaceuticals, Inc. Rockville MD
2. Supernus Pharmaceuticals, Inc. Rockville MD
Correspondent
- Mark Simpson
- SAUL EWING ARNSTEIN & LEHR
- CENTRE SQUARE WEST, 38TH FLOOR
- 1500 MARKET STREET
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG